Synrad's Scientific Advisory Committee expands capacity and determines the PI for clinical trials in the United States

Beijing, October 13, 2021/PRNewswire/ - Recently, Synerdyne’s scientific advisory committee welcomed 4 world-leading medical experts to join, of which 3 will serve as Synerdyne’s AcoArt under-knee drug-coated balloon (BTK) Registered clinical PI in the United States

The four new top experts who have joined this time have extremely rich experience and cutting-edge insights in the field of peripheral intervention.

Dr.

Dr.

Dr.

Professor Thomas Zeller, a well-known German vascular interventional expert, is the head of the Department of Angiology at the University Heart Center Freiburg/Bad Krozingen in Germany.

With the addition of experts, the AcoArt BTK Global IDE Study (AcoArt BTK Global IDE Study) in the United States has also entered an accelerated period

Prior to this, AcoArt Tulip™ & Litos™, a BTK product of Trinidad, has been awarded the "Breakthrough Device" certification by the U.

Li Jing, co-founder and CEO of Synrad, said, “I feel very honored to be recognized by the four top experts in the industry, and sincerely welcome them to join

Prior to this, Synreda's DCB products have been approved in 12 countries around the world, including Germany, Italy, Switzerland, Spain, etc.

【About Xianruida】

Advanced Medical Technology Holdings Co.

Synrad has two R&D centers in Beijing and Shenzhen, and its scientific advisory committee members are all over China, the United States and Europe, including renowned experts from all over the world.

Internationally, Synreda has exported its products to 12 countries, including Germany, Italy, Switzerland, Spain, etc.

Source: Beijing Xianruida Medical Technology Co.